Kamada (KMDA) Shares Outstanding (Diluted Average) (2012 - 2026)
Kamada (KMDA) reported Shares Outstanding (Diluted Average) of $70.0 for Q1 2026, little changed on a YoY basis from $70.0 in Q1 2025, and down 80.0% quarter-over-quarter from $350.0 in Q4 2025.
Kamada (KMDA) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends
Kamada has reported Shares Outstanding (Diluted Average) for 15 years, with the latest figure at $70.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $70.0; the trailing twelve-month figure through Mar 2026 stood at $70.0 (changed 0.0% YoY), and the FY2025 full-year result was $350.0, up 40.0% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $70.0, down from $350.0 in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $350.0 in Q4 2025, with the low at $40.0 in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $130.0 across 5 years, with a median of $120.0 in 2022.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) slumped 69.23% — and 2024, when it surged 200.0%.
- Kamada's Shares Outstanding (Diluted Average) stood at $70.0 in 2022, then surged by 114.29% to $150.0 in 2023, then soared by 66.67% to $250.0 in 2024, then jumped by 40.0% to $350.0 in 2025, then tumbled by 80.0% to $70.0 in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $70.0 (Q1 2026), $350.0 (Q4 2025), and $290.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn | 70.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.00 |
| Dec 31, 2025 | 350.00 |
| Sep 30, 2025 | 290.00 |
| Jun 30, 2025 | 190.00 |
| Mar 31, 2025 | 70.00 |
| Dec 31, 2024 | 250.00 |
| Sep 30, 2024 | 180.00 |
| Jun 30, 2024 | 120.00 |
| Mar 31, 2024 | 40.00 |
| Dec 31, 2023 | 150.00 |
| Sep 30, 2023 | 60.00 |
| Jun 30, 2023 | 40.00 |
| Mar 31, 2023 | 40.00 |
| Dec 31, 2022 | 70.00 |
| Sep 30, 2022 | 120.00 |
| Jun 30, 2022 | 130.00 |
| Mar 31, 2022 | 40.00 |
| Dec 31, 2021 | 110.00 |
| Sep 30, 2021 | 60.00 |
| Jun 30, 2021 | 80.00 |